Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders??? Equity (Unaudited)

v3.19.3
Consolidated Statements of Stockholders’ Equity (Unaudited) - 9 months ended Sep. 30, 2019 - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 27,949 $ 38,796,562 $ (8,765,992) $ 30,058,519
Balance shares at Dec. 31, 2018 27,948,609      
Sale of Common stock and warrants, net of fees $ 4,123 12,872,416   12,876,539
Sale of Common stock and warrants, net of fees,shares 4,123,254      
Share based compensation   256,551   256,551
Common stock issued upon warrant exercise $ 1,722 1,262,406   1,264,128
Common stock issued upon warrant exercise, shares 1,722,463      
Common stock issued upon cashless exercise of options $ 506 (506)  
Common stock issued upon cashless exercise of options, shares 505,868      
Common stock issued in connection with business combinations $ 894 3,338,737   3,339,631
Common stock issued in connection with business combinations, shares 894,553      
Common stock issued upon conversion of convertible debt $ 1,259 2,309,573   2,310,832
Common stock issued upon conversion of convertible debt, shares 1,258,608      
Common stock issued for services $ 99 132,748   132,847
Common stock issued for services, shares 98,750      
Common stock issued for accrued share-based compensation $ 100 210,100   210,200
Common stock issued for accrued share-based compensation, shares 100,000      
Net income     2,341,120 2,341,120
Balance at Sep. 30, 2019 $ 36,652 $ 59,178,587 $ (6,424,872) $ 52,790,367
Balance shares at Sep. 30, 2019 36,652,105